XML 61 R51.htm IDEA: XBRL DOCUMENT v3.24.1.u1

Commitments and Contingencies - Tradipitant - Additional Information (Details) - Tradipitant - USD ($) $ in Millions	3 Months Ended	12 Months Ended	144 Months Ended
	Mar. 31, 2024	Dec. 31, 2023	Mar. 31, 2024
Commitments and Contingencies [Line Items]
Future percentage of royalty payments based net sales	low double digits
Development and milestone obligations paid to third party			$ 5.0
Pre-NDA Approval Milestones
Commitments and Contingencies [Line Items]
Possible future milestone payment		$ 2.0
Regulatory Approval Milestone | U.S.
Commitments and Contingencies [Line Items]
Possible future milestone payment	$ 10.0
Regulatory Approval Milestone | E.U.
Commitments and Contingencies [Line Items]
Possible future milestone payment	5.0
Sales Milestone
Commitments and Contingencies [Line Items]
Possible future milestone payment	$ 80.0

X

- Definition

Commitments and contingencies.

+ References

No definition available.

+ Details

Name:	vnda_CommitmentsAndContingenciesLineItems
Namespace Prefix:	vnda_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Development And Milestone Obligations Paid To Third Party

+ References

No definition available.

+ Details

Name:	vnda_DevelopmentAndMilestoneObligationsPaidToThirdParty
Namespace Prefix:	vnda_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

Total amount potentially due to third party under license agreement based on achievement of pre-new drug application approval milestones.

+ References

No definition available.

+ Details

Name:	vnda_DevelopmentAndMilestonePaymentsPotentiallyDueToThirdParty
Namespace Prefix:	vnda_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

Future Percentage Of Royalty Payments Based On Net Sales.

+ References

No definition available.

+ Details

Name:	vnda_FuturePercentageOfRoyaltyPaymentsBasedOnNetSales
Namespace Prefix:	vnda_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	us-gaap_TypeOfArrangementAxis=vnda_TradipitantMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=vnda_PreNDAApprovalMilestonesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=vnda_RegulatoryApprovalMilestoneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_StatementGeographicalAxis=country_US
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_StatementGeographicalAxis=srt_EuropeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=vnda_SalesMilestoneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: